TY - JOUR
T1 - Premature ovarian insufficiency
T2 - an International Menopause Society White Paper
AU - Panay, N.
AU - Anderson, R. A.
AU - Nappi, R. E.
AU - Vincent, A. J.
AU - Vujovic, S.
AU - Webber, L.
AU - Wolfman, W.
PY - 2020
Y1 - 2020
N2 - The aim of this International Menopause Society White Paper on premature ovarian insufficiency (POI) is to provide the latest information regarding this distressing condition. The impact of POI has far-reaching consequences due to its impact on general, psychological, and sexual quality of life, fertility prospects, and long-term bone, cardiovascular, and cognitive health. Progress in fully understanding the etiology, diagnosis, and optimal management options has been slow thus far due to the complexity of the condition and fragmented research. Recent advances in epidemiological and genetic research have improved our understanding of this condition and randomized prospective trials are being planned to determine the intervention strategies, which will optimize quality of life and long-term well-being. The International Menopause Society has commissioned a number of experts at the forefront of their specialty to define the state of the art in the understanding of this condition, to advise on practical management strategies, and to propose future research strategies. It is hoped that a global task force will subsequently be convened in order to formulate a consensus statement across key societies, to accelerate date collection and analysis of a global POI registry, and to facilitate progress in the key defined areas of research.
AB - The aim of this International Menopause Society White Paper on premature ovarian insufficiency (POI) is to provide the latest information regarding this distressing condition. The impact of POI has far-reaching consequences due to its impact on general, psychological, and sexual quality of life, fertility prospects, and long-term bone, cardiovascular, and cognitive health. Progress in fully understanding the etiology, diagnosis, and optimal management options has been slow thus far due to the complexity of the condition and fragmented research. Recent advances in epidemiological and genetic research have improved our understanding of this condition and randomized prospective trials are being planned to determine the intervention strategies, which will optimize quality of life and long-term well-being. The International Menopause Society has commissioned a number of experts at the forefront of their specialty to define the state of the art in the understanding of this condition, to advise on practical management strategies, and to propose future research strategies. It is hoped that a global task force will subsequently be convened in order to formulate a consensus statement across key societies, to accelerate date collection and analysis of a global POI registry, and to facilitate progress in the key defined areas of research.
KW - bone health
KW - cardiometabolic health
KW - cognitive health
KW - fertility
KW - hormone therapy
KW - oocyte donation
KW - Premature ovarian insufficiency
KW - reproductive health
UR - http://www.scopus.com/inward/record.url?scp=85090465059&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090465059&partnerID=8YFLogxK
U2 - 10.1080/13697137.2020.1804547
DO - 10.1080/13697137.2020.1804547
M3 - Review article
AN - SCOPUS:85090465059
SN - 1369-7137
JO - Climacteric
JF - Climacteric
ER -